维普中文期刊产品整合服务
110篇 您的检索式:作者名="van GAAL L"
    题名 作者 年代 出处 被引量
1A review of current evidence with continuous glucose monitoring in patients with diabetes显示文摘de Block C Manuel-y-Keenoy B van Gaal L 2008J Diabetes Sci Technol2008,2,4:1
2Nateglinide improves glycaemic control when added to metformin monotherapy:results of a randomized trial with type 2 diabetes patients显示文摘Marre M Van Gaal L Usadel KH Diabetes0,,:1
3Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome:a position paper developed by a European Consensus Panel显示文摘Shepherd J Betteridge J van Gaal L 2005Curr Med Res Opin2005,21,5:1
4Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes显示文摘Heine R J Van Gaal L F Johns D 2005Ann Intern Med2005,143,8:1
5Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial显示文摘DIAMANT M van GAAL L STRANKS S et ol 2010Lancet2010,375,9733:1
6Myocardial infarction after percutaneous coronary intervention:a meta-analysis of troponin elevation applying the new universal definition显示文摘Testa L Van Gaal WJ Biondi Zoccai GG 2009QJM2009,102,6:1
7Overweight, obesity, and outcomes:fat mass and beyond 显示文摘Van Gaal L F Maggioni A P 2014Lancet2014,383,9921:1
8Effects of Liraglutide in the treatment of obesity:a randomized,double- blind,placebo-controlled study显示文摘Astrup A RSssner S Van Gaal L 2009Lancet2009,374,9701:1
9Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo- controlled study显示文摘Astrup A ROssner S Van Gaal L 2009Lancet2009,374,9701:1
10Exenatide versus insulin glargine in patients with suboptireally controlled type 2 diabetes: a randomized trial 显示文摘HEINE R J VAN GAAL L F JOHNS D 2005Ann Intern Med2005,143,8:1
11Exenatide versus insulin glargine in pa- fients with suboptimally controlled type 2 diabetes: a randomized trial显示文摘Heine R J van Gaal L F Johns D ct al 2005Ann Intern Med2005,143,8:1
12Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel 显示文摘Shepherd J Betteridge J van Gaal L 2005Curr Med Res Opin2005,21,5:1
13Insulin resistance and environmental pollutants: experimental evidence and future perspectives显示文摘Hectors T L Vanparys C Van Gaal L F 2013Environ Health Perspect2013,121,1112:1
14Once weekly exenatidecompared with insulin glargine titrated to target in patients with type2 diabetes(DURATION-3): an open-label randomised trial显示文摘Diamant M Van Gaal L Stranks S 2010Lancet2010,375,9733:1
15Exenatide once weekly versus insulin glargine lbr type 2 diabetes(DURATION-3): 3-year results of an open-label randomised trial显示文摘Diamant M Van Gaal L Guerci B 2014Lancet Diabetes Endocrinol2014,2,6:1
16Relationship betweenHbAlc levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-riskwomen and men with type 2 diabetes显示文摘Andersson C van Gaal L Caterson ID 2012Diabetologia2012,55,9:1
17Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study 显示文摘Astrup A Rfissner S Van Gaal L 2009Lancet2009,374,9701:1
18Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study显示文摘Astrup A Rossner S Van Gaal L 2009Lancet2009,374,9701:1
19Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trial显示文摘Verhoeven V Van der Auwera A Van Gaal L 2015BMC Complement Altem Meal2015,15,1:1
20Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study显示文摘Astrup A Rossner S Van Gaal L 2009Lancet2009,374,9701:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费